The Biden administration must update requirements for insurer contraceptive coverage to help states better prepare for the first daily over-the-counter oral birth control pill expected to soon hit US retail shelves, reproductive health groups and policy analysts say.
Opill, which the Food and Drug Administration in July approved to be offered without a prescription, will be available in stores and online nationwide in “early 2024,” according to
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.